Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Washington
With
CLL Global Research Foundation
OUTLINE:
For patients who have not been vaccinated at the time of enrollment, they will undergo collection of blood samples prior to the first vaccine dose, just before the second vaccine dose, and then at 1, 6, and 12 months after the second vaccine dose. Patients' medical records are also reviewed.
For patients enrolled after vaccination, they will undergo collection of blood samples at 1-4, 6, and 12 months after completing the vaccination series. Patients who receive booster dose also undergo collection of blood samples at 1, 6, and 12 months post final booster dose.
After completion of study, patients are followed up every 6 months for 2 years.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age \>= 18 years
A diagnosis of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
Willing and able to participate in all required evaluations and procedures in this study
You may not be if
Any evidence of prior SARS-CoV-2/COVID19 infection